By inhibiting neutrophil activation, relaxin-2 may help regulate maternal immune responses, suggesting a potential role in early pregnancy processes relevant to preeclampsia, a disorder associated with excessive inflammation [71]. This evidence concerns the gene RLN2 and preeclampsia.